Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life

NCT03420235 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Erasmus Medical Center

Collaborators